Is the management of hepatitis C patients appropriate? A population-based study

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 8, 2005, Pages 1007-1015

  Hatem, C ^a   Minello, A ^a   Bresson Hadni, S ^b   Jooste, V ^a   Evrard, P ^b   Obert, B ^b   Lepage, C ^a   Bonithon Kopp, C ^a   Faivre, J ^a   Monnet, E ^b   Miguet, J P ^b   Hillon, P ^a,c  

^a Faculte de Medecine de Dijon   (France)

^b UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^c HÔPITAL DU BOCAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD DONOR; DRUG DEPENDENCE; FEMALE; FRANCE; HEPATITIS C; HIGH RISK PATIENT; HUMAN; LIFESTYLE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; METAVIR SCORE; PATIENT CARE; PATIENT MONITORING; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; DELIVERY OF HEALTH CARE; EARLY DIAGNOSIS; FEMALE; FRANCE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; RURAL HEALTH; SEVERITY OF ILLNESS INDEX; TIME FACTORS; URBAN HEALTH;

EID: 20244371962     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02393.x     Document Type: Article

References (25)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52.
2. Williams I. Epidemiology of hepatitis C in the United States. Am J Med 1999; 107(Suppl.):2S-9S.
3. Wong JB, Mc Quillan GM, Mc Hutchinson JG, et al. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000; 90: 1562-1569.
4. Tiné F, Magrin S, Craxi A, et al. Interferon in nonA-nonB hepatitis: a meta-analysis of randomised clinical trials. J Hepatol 1991; 13: 192-9.
5. Manns MP, Mc Hutchinson JG, Gordon SC, et al. Peginterferon alpha-2b plus ribavirin compared to interferon alpha-2b and ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-65.
6. Monnet E, Mercet P, Woronoff-Lemsi MC, et al. Dépistage organisé de l'hépatite virale C. Résultats et coût d'un an de campagne dans un département pilote. Gastroenterol Clin Biol 2000; 24: 541-6.
7. Bonaguidi-Magniaux M, Pilette C, Oberti F, et al. Le suivi des donneurs de sang ayant une sérologie du virus de l'hépatite C positive et de leurs receveurs est insuffisant. Gastroenterol Clin Biol 1996; 20: 663-8.
8. Julien AM. Suivi médical des donneurs de sang porteurs d'anticorps contre le virus de l'hépatite C. Gastroentérol Clin Biol 1996; 20: 657-8.
9. Ryan KE, MacLennan S, Barbara JAJ, et al. Follow up of blood donors positive for antibodies to hepatitis C virus. BMJ 1994; 308: 696-7.
10. Goegebeur G, Benhamiche AM, Minello A, et al. Les caractéristiques des malades ayant des anticorps dirigés contre le virus de l'hépatite C sont différentes en service spécialisé hospitalo-universitaire et dans la population générale. Gastroenterol Clin Biol 2000; 24: 1042-1046.
11. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24; 289-93.
12. The French Metavir Cooperative Study Group. Infra-observer and inter-observer variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
13. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 248-75.
14. University of California Press. BMDP Statistical Software Manual. Vol 1 and Vol 2. Berkeley: University of California Press, 1992.
15. Sahajian F, Bailly F, Caillat-Vallet E, et al. Prise en charge médicale des malades séropositifs pour le virus de l'hépatite C. Gastroenterol Clin Biol 2001; 25: 262-7.
16. Sahajian F, Caillat-Vallet E, Bailly F, et al. Pratique des médecins généralistes en matière de dépistage du virus de l'hépatite C dans la région lyonnaise. Santé Publique 1999; 4: 513-25.
17. la Conférence de Consensus. Conclusions et recommandations du jury. Hépatite C: dépistage et traitement. Gastroentérol Clin Biol 1997; 20(Suppl.):S202-11.
18. Hillebrand J, Marsden J, Finch E, et al. Excessive alcohol consumption and drinking expectations among clients in methadone maintenance. J Subst Abuse Treat 2001; 21; 155-160.
19. EASL. EASL International Consensus Conference on Hepatitis C: Paris, 26-28, February 1999. consensus statement. J Hepatol 1999; 30: 956-61.
20. National Institutes of Health Consensus Development, National institutes of health consensus development conference panel statement; management of hepatitis C. Hepatology 1997; 26(Suppl.):2S-10S.
21. Yawn BP, Wollan P, Gazzuola L, et al. Diagnosis and ten-year follow-up of a community-based hepatitis C cohort. J Fam Pract 2002; 51: 135-140.
22. Falck-Ytter Y, Kale H, Müllen KD, et al. Surprisingly small effect of antiviral treatment in patients with hepatitis C. Ann Intern Med 2002; 136: 288-92.
23. Frere T, Verneau A. Besson I, et al. Prise en charge de l'infection par le virus de l'hépatite C dans la région Poitou-Charentes. Gastroenterol Clin Biol 1999; 23: 887-91.
24. Raysiguier R, Bonny C, Abergel C, et al. Pratiques et attentes des médecins généralistes en matière d'hépatite C dans la région Auvergne. Gastroenterol Clin Biol 2001; 25: A67.
25. Consensus Conference. Treatment of hepatitis C. Gastroenterol Clin Biol 2002; 26: B312-20.